Search

everythinglearnresearchcommunity

for

Search:↓

Nizoral improved menstrual cycles and reduced hair growth in patients with hyperandrogenism.

Genetic response to androgens is key in female pattern baldness, not SHBG levels.

The conclusion is that there's a link between high testosterone levels, insulin resistance, and certain skin conditions, regardless of obesity.

Topical minoxidil is the best-supported treatment for female hair loss, but personalized plans are needed.

PCOS symptoms can be managed with medication and lifestyle changes.

Female pattern hair loss in Western India is common and often linked to metabolic syndrome.

Finasteride can cause lasting skin lightening in women.

PCOS is a hormonal issue in women that is usually treated with birth control pills, metformin, and lifestyle changes, with early treatment helping to reduce complications and improve life quality.

Androgen-producing ovarian tumors can cause male-pattern hair loss in women.

Lab tests for female hair loss have unclear usefulness; consider based on symptoms.

Using a combined treatment of minoxidil and metformin can improve hair loss in women by normalizing hormone and metabolism levels.

Hair loss in women can be caused by genetics, menopause, certain health conditions, and emotional stress, and it often results in thinner hair and a changing hairline.

Proper medical treatments can control and even reverse female pattern hair loss, but it's important to check for related conditions like excessive male hormone production, especially in severe cases.

Both finasteride and metformin effectively treat PCOS by reducing hormone levels and insulin resistance.

Women with androgenetic alopecia often have other symptoms of high androgen levels, requiring further hormone testing.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

The ovary mainly causes high testosterone in PCO, while the adrenal gland is the main source in IH.

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Cyproterone acetate with estradiol may subjectively improve excessive hair growth in women, but it's not clinically better than other treatments.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

About 3% of high school girls aged 14-18 in Isfahan, Iran, have polycystic ovary syndrome.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

Early adrenal gland maturation in young children can be normal, but other serious conditions should be ruled out first.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Hirsutism in women is mostly caused by polycystic ovary syndrome and idiopathic hyperandrogenism.